Following this transaction, Posner holds 13,692 shares of Cara Therapeutics. The reported shares reflect a 1-for-12 reverse stock split that occurred on December 30, 2024. With the company's next ...

Christopher Posner, President and CEO of Cara Therapeutics Inc. (NASDAQ:CARA), a small-cap biotech company with a market capitalization of $23.22 million, recently sold shares of the company's common ...

The average 1 year target price among brokers that have issued ratings on the stock in the last year is $27.84. Separately, StockNews.com initiated coverage on Cara Therapeutics in a research ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

After hours: February 7 at 5:54:09 PM EST Loading Chart for CARA ...

At close: February 6 at 4:00:02 PM EST ...

After hours: February 7 at 5:54:09 p.m. EST ...